Colin G. Sandercock's Insider Trades & SAST Disclosures

Colin G. Sandercock's most recent trade in Cue Biopharma Inc was a trade of 200,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 21, 2025.

Share

Note

This is a custom search result for pattern Colin G. Sandercock.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Cue Biopharma Inc	Colin G. Sandercock	SVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Mar 2025	200,000	200,000	-		-	Stock Option (right to buy)
Cue Biopharma Inc	Colin G. Sandercock	SVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Jun 2024	60,000	60,000	-		-	Stock Option (right to buy)
Cue Biopharma Inc	Colin G. Sandercock	SVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Mar 2024	175,000	175,000	-		-	Stock Option (right to buy)
Cue Biopharma Inc	Colin G. Sandercock	SVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2023	75,000	75,000	-		-	Stock Option (right to buy)
Cue Biopharma Inc	Colin G. Sandercock	SVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2023	100,000	100,000	-		-	Stock Option (right to buy)
Cue Biopharma Inc	Colin G. Sandercock	SVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2022	60,000	60,000	-		-	Stock Option (right to buy)
Cue Biopharma Inc	Colin G. Sandercock	SVP, GENERAL COUNSEL	Grant, award, or other acquisition of securities at price $ 0.00 per share.	09 Feb 2022	16,667	16,667	-		-	Stock Option (right to buy)
Cue Biopharma Inc	Colin G. Sandercock	SVP, General Counsel and Sec	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Feb 2021	50,000	50,000	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades